We will know soon
http://www.nytimes.com/2009/02/20/us/politics/20health.html?_r=1&ref=health&pagewanted=printFebruary 20, 2009
Health Care Industry in Talks to Shape Policy
By ROBERT PEAR
WASHINGTON — Since last fall, many of the leading figures in the nation’s long-running health care debate have been meeting secretly in a Senate hearing room. Now, with the blessing of the Senate’s leading proponent of universal health insurance, Edward M. Kennedy, they appear to be inching toward a consensus that could reshape the debate.
Many of the parties, from big insurance companies to lobbyists for consumers, doctors, hospitals and pharmaceutical companies, are embracing the idea that comprehensive health care legislation should include a requirement that every American carry insurance.
.........
The talks, which are taking place behind closed doors, are unusual. Lobbyists for a wide range of interest groups — some of which were involved in defeating national health legislation in 1993-4 — are meeting with the staff of Mr. Kennedy, Democrat of Massachusetts, in a search for common ground.
.................
While President Obama is not directly represented in the talks, the White House has been kept informed and is encouraging the Senate effort as a way to get the ball rolling on health legislation.
...............
“While there was some diversity of views,” it said, “the sense of the room is that an individual obligation to purchase insurance should be part of reform if that obligation is coupled with effective mechanisms to make coverage meaningful and affordable.”
The ideas discussed include a proposal to penalize people who fail to comply with the “individual obligation” to have insurance.
......................................
The 20 people who regularly attend the meetings on Capitol Hill include lobbyists for AARP, Aetna, the A.F.L.-C.I.O., the American Cancer Society, the American Medical Association, America’s Health Insurance Plans, the Business Roundtable, Easter Seals, the National Federation of Independent Business, the Pharmaceutical Research and Manufacturers of America, and the United States Chamber of Commerce.